Heat Intolerance Cross-Disease Bridges
(Certainty: 0.35.) Uhthoff’s phenomenon — transient worsening of neurological symptoms with increased body temperature — is well-documented in multiple sclerosis, where demyelinated axons fail to conduct action potentials at elevated temperatures due to reduced safety factor. ME/CFS patients also report heat-triggered worsening of fatigue, cognitive function, and orthostatic intolerance. If SFN-mediated demyelination or nodal sodium channel dysfunction occurs in ME/CFS (analogous to MS), temperature-dependent conduction block could explain heat-triggered neurological symptom exacerbation. This would be testable via nerve conduction studies at controlled skin temperatures (25°C vs 35°C) in SFN+ ME/CFS patients. Falsifiable: SFN+ ME/CFS patients show greater temperature-dependent conduction velocity slowing than SFN- ME/CFS and healthy controls. No ME/CFS MS-parallel heat challenge studies exist.
(Certainty: 0.45.) Fibromyalgia patients demonstrate thermal hyperalgesia (lowered heat and cold pain thresholds) and temporal summation of thermal stimuli — classical central sensitization features. ME/CFS patients also show generalized hyperalgesia to heat and mechanical stimuli, with absent conditioned pain modulation. The two conditions share central sensitization as a thermoregulatory symptom amplifier: thermal discomfort that a healthy person would perceive as neutral is processed as noxious. This cross-condition overlap suggests that thermoregulatory symptoms in both conditions are amplified by central sensitization, not purely peripheral mechanisms. Falsifiable: quantitative sensory testing of heat pain threshold will correlate positively between ME/CFS and fibromyalgia patients (r > 0.4) after controlling for autonomic dysfunction severity.
(Certainty: 0.40.) Long COVID shares thermoregulatory symptoms with ME/CFS (heat/cold intolerance, temperature instability, night sweats). The persistence of thermoregulatory dysfunction >12 months post-infection in both conditions suggests a common post-viral mechanism rather than acute-phase residual. If validated, thermoregulatory impairment duration could serve as a post-viral illness severity biomarker that is cheaper and more accessible than specialized immune assays. Falsifiable: ME/CFS and Long COVID patients show equivalent skin temperature circadian rhythm disruption (amplitude, phase) after matching for illness duration; thermoregulatory impairment does not distinguish between the two conditions. No comparative ME/CFS–Long COVID thermoregulatory phenotyping study exists.
(Certainty: 0.35.) POTS involves microvascular denervation with reduced perivascular sympathetic innervation of arterioles, documented via reduced tyrosine hydroxylase staining on skin biopsy. ME/CFS has high POTS comorbidity. This shared denervation could underlie the vasomotor failure common to both conditions: denervated vessels cannot constrict adequately during orthostasis (POTS) nor dilate adequately during heat stress (ME/CFS thermoregulatory failure). The prediction is that ME/CFS-POTS patients with the most severe thermoregulatory symptoms should show the greatest perivascular denervation. Falsifiable: skin biopsy tyrosine hydroxylase density correlates (r above 0.6) with combined orthostatic + thermoregulatory symptom severity. No study has measured perivascular innervation specifically in relation to thermoregulation in ME/CFS.
(Certainty: 0.25.) Raynaud’s disease involves TRPA1 and TRPM8-mediated cold-induced vasospasm. ME/CFS cold intolerance may involve analogous TRP channel dysfunction given the documented TRPM3 channelopathy. If the TRP channel dysfunction in ME/CFS extends beyond TRPM3 to cold-sensitive TRPA1/TRPM8, cold intolerance would reflect excessive cold-induced vasoconstriction rather than (or in addition to) failed BAT thermogenesis. Falsifiable: ME/CFS patients with cold intolerance show reduced TRPA1/TRPM8 calcium influx in vitro and exaggerated vasoconstriction to cold stimulus (laser Doppler perfusion decreased 60% at 15°C vs 30% in controls). No ME/CFS TRPA1/TRPM8 data.
(Certainty: 0.30.) Hypothyroidism causes brown adipose tissue dysfunction and cold intolerance via impaired sympathetic-BAT coupling. ME/CFS patients with cold intolerance may share this mechanism even with normal thyroid function: sympathetic dysregulation produces functional BAT failure that mimics the thyroid-deficient state. The differential diagnosis is important because subclinical hypothyroidism and ME/CFS cold intolerance are clinically indistinguishable without laboratory testing. Falsifiable: ME/CFS patients with cold intolerance show absent BAT activation on PET-CT independent of TSH levels; mirabegron (β3-agonist) restores BAT uptake even with normal thyroid function. No ME/CFS BAT imaging data.